2019
DOI: 10.2478/amb-2019-0017
|View full text |Cite
|
Sign up to set email alerts
|

The Heparanase Inhibitor (Sulodexide) Decreases Urine Glycosaminoglycan Excretion and Mitigates Functional and Histological Renal Damages in Diabetic Rats

Abstract: Background/objectives: Recent data suggest a role for heparanase in several proteinuric conditions. An increased glomerular heparanase expression is associated with loss of heparan sulfate in the glomerular basement membrane (GBM). The aim of the present study was to investigate the renal effects of heparanase inhibition in a diabetic experimental model. Methods: Fifteen male Wistar rats (230 ± 20 g) were divided into three groups: 1) controls, 2) diabetics (STZ, 50 mg/kg, dissolved in saline, ip), 3) diabetic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Sulodexide is a glycosaminoglycan that comprises two fractions: fast-moving heparin fraction (80%) that has affinity for antithrombin III, plus a dermatan sulfate fraction (20%) that has affinity for heparin cofactor II [18]. Experimental investigations showed a favorable effect of sulodexide in diabetic rats, not only reducing proteinuria [19,20] but also protecting the endothelial morphology and function [21][22][23]. This could be associated with a protective and regenerating action on the glycocalyx in experimental studies [24][25][26][27] and in humans [28].…”
Section: Introductionmentioning
confidence: 99%
“…Sulodexide is a glycosaminoglycan that comprises two fractions: fast-moving heparin fraction (80%) that has affinity for antithrombin III, plus a dermatan sulfate fraction (20%) that has affinity for heparin cofactor II [18]. Experimental investigations showed a favorable effect of sulodexide in diabetic rats, not only reducing proteinuria [19,20] but also protecting the endothelial morphology and function [21][22][23]. This could be associated with a protective and regenerating action on the glycocalyx in experimental studies [24][25][26][27] and in humans [28].…”
Section: Introductionmentioning
confidence: 99%